Research catalogue and document reference
October 24, 2026
For example, a report naming the right peptide but showing a different lot number does not establish a match. Nor does one sample result prove that every vial in the batch has identical composition. Keep the scope precise: the document records findings for the specified sample, method and fields. It does not automatically show that the sample represents every vial.
Check whether the vial’s lot number can be matched through an online batch verification lookup. Use the identifier printed on the vial, not a compound name alone. A report identifier can also distinguish one analytical document from another, while the lot number ties the record to the product batch. Record both when reviewing results.
Mass spectrometry for molecular identity confirmation
LC-MS and Molecular Identity
Start with the report’s stated theoretical and observed masses. The observed mass should be within 0.1-0.5 Daltons of the theoretical mass for identity confirmation. Interpretation depends on the instrument and method: ESI-MS analysis of small-medium peptides has a stated accuracy range of ±0.01-0.1 Da, while MALDI-TOF analysis of larger peptides and proteins has a stated range of ±0.1-1.0 Da. A mass match of ±1 Da or less is typically described as acceptable for ESI-MS peptide analysis.
Product and sample identifiers connect a mass result to the peptide and material named in the report. Check that the compound name and sample identifier match the associated product records. Without that link, the mass result may describe a different sample, even if its proposed identity seems relevant.
Trace the laboratory, method and sample record before relying on an independent result. Review research peptide documentation alongside these checks.
Aussie Peptides: BPC-157
To review BPC-157 batch documentation, visit Aussie Peptides.
Make verifying a peptide certificate of analysis part of a consistent documentation practice. Record the decision, the material’s intended research context and the evidence used to assess its suitability for that work. This creates a traceable basis for later review instead of relying on an isolated document or informal recollection.
Aussie Peptides offers BPC-157, Retatrutide and Semaglutide for laboratory research use, not human consumption. Select materials according to your research requirements and keep the relevant product documentation with your laboratory records. A clear paper trail supports reproducibility and helps distinguish product selection from conclusions drawn from experimental results.
For questions about these research offerings or their documentation, contact Aussie Peptides with your questions. Continue applying the same evidence-led standard to each research decision, and your records will remain easier to assess and reproduce.
What information should a peptide certificate of analysis include?
Materials in this catalogue are offered for in-vitro laboratory research only, not human or veterinary use. This reference does not provide dosing, preparation, storage or treatment instructions.
Check the listing identity
Read the compound name, labelled amount and any blend composition on the current product listing. An amount per vial is not a dose or a preparation protocol. Current prices and availability belong to the catalogue, not an older article.
Check a lot document, where published
A report is shown only if one has been published for that lot. Compare its identifiers with the listing and vial label. A missing report is not evidence of testing or quality.
Consult the appropriate source
For handling, consult the supplier safety data sheet and your institution's standard operating procedures. For regulatory questions, consult official TGA guidance; a research-use label does not determine legal status.
Research catalogue · Lot documents · Official guidance · Shipping details and carrier estimates · Contact